Company profile

VinBrain Joint Stock Company

VinBrain Joint Stock Company has 2 AI-enabled medical devices on the FDA list. The first decision was on September 1, 2022 and the most recent on December 6, 2024 (DrAid for Liver Segmentation). Its most common review panel is Radiology (2 devices).

2AI devices

2022First decision

2024Latest decision

1Specialties

Related guides

Top radiology devices

Timeline

December 6, 2024 · 510(k) K241543DrAid for Liver Segmentation · Radiology · QIH
September 1, 2022 · 510(k) K221241DrAid for Radiology v1 · Radiology · QFM